For the quarter ending 2026-03-31, STIM made $34,454K in revenue. -$10,790K in net income. Net profit margin of -31.32%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenue | 34,454 | 41,777 | 37,297 | 38,108 |
| Product | 2,858 | 4,116* | - | - |
| Service | 15,442 | 15,957* | - | - |
| Total cost of revenues | 18,300 | 20,073 | 20,189 | 20,350 |
| Gross profit | 16,154 | 21,704 | 17,108 | 17,758 |
| Sales and marketing | 10,737 | 11,743 | 11,848 | 11,868 |
| General and administrative | 13,048 | 13,338 | 11,077 | 12,150 |
| Research and development | 1,364 | 1,666 | 1,504 | 1,798 |
| Total operating expenses | 25,149 | 26,747 | 24,429 | 25,816 |
| Loss from operations | -8,995 | -5,043 | -7,321 | -8,058 |
| Interest expense | 2,266 | 2,318 | 2,206 | 1,969 |
| Loss on extinguishment of debt | -539 | - | - | - |
| Other income, net | 1,020 | 155 | 126 | 188 |
| Net loss | -10,780 | -7,206 | -9,401 | -9,839 |
| Less net gain (loss) attributable to non-controlling interest | 10 | -48 | -356 | 281 |
| Net loss attributable to neuronetics stockholders' | -10,790 | -7,158 | -9,045 | -10,120 |
| Basic EPS | -0.16 | -0.104 | -0.13 | -0.15 |
| Diluted EPS | -0.16 | -0.104 | -0.13 | -0.15 |
| Basic Average Shares | 69,589,000 | 68,850,000 | 67,309,000 | 66,180,000 |
| Diluted Average Shares | 69,589,000 | 68,850,000 | 67,309,000 | 66,180,000 |
Neuronetics, Inc. (STIM)
Neuronetics, Inc. (STIM)